Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 3 16Phase NA 7Phase 1 4Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 4

Conditions

Ovarian Neoplasms 4Colorectal Neoplasms 2Appendiceal Neoplasms 2Uterine Neoplasms 1Stomach Neoplasms 1Recurrence 1Peritoneal Neoplasms 1Neoplasm Metastasis 1

Interventions

Paclitaxel 108Carboplatin 96pembrolizumab 63Cisplatin 62Cyclophosphamide 44Bevacizumab 35Taxes 31Gemcitabine 28liposomal doxorubicin 27Topotecan 26fludarabine 24olaparib 22Nivolumab 20Docetaxel 20Radiotherapy 18Brachytherapy 17veliparib 16Magnetic Resonance Spectroscopy 16Doxorubicin 16Biopsy 15Radiation 14niraparib 13aldesleukin 13Specimen Handling 13Platinum 13Oxaliplatin 13Filgrastim 13Albumin-Bound Paclitaxel 12atezolizumab 11Interleukin-2 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Hyperthermic Intraperitoneal Chemotherapy × Gynecologic × Clear all
NCT04329494 2025-12-10

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center

Phase 1 Recruiting
49 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT02672098 2025-05-22

Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer

Loma Linda University

Phase 1 Completed
3 enrolled
Gynecologic

Ovarian Neoplasms

NCT06216561 2024-08-20

Intraperitoneal LSTA1 in CRS-HIPEC

University of California, San Diego

Phase 1 Withdrawn
GastrointestinalGynecologic

Appendiceal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02475772 2022-07-08

A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis

Ruhr University of Bochum

Phase 1 Completed
15 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡